Search
From Date :
To Date :
Serivce :
Query :
Keywords :
 ( Seprate With , )
Scientists kill cancer cells by “shutting the door” to nucleus – may lead to new type of cancer treatment
Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that blocking the construction of nuclear pores complexes – large channels that control the flow of materials in and out of the cell nucleus – shrank aggressive tumors in mice while leaving healthy cells unharmed. The study, published in Cancer Discovery, a journal of the American Association for Cancer Research, reveals a new Achilles heel for cancer that may lead to better treatments for deadly tumors such as melanoma, leukemia and colorectal cancer, scitechdaily.com reported.
Immunotherapy improves survival in advanced bladder cancer patients
An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a Phase III clinical trial led by Queen Mary University of London and Barts Cancer Center, the UK.
Coffee linked to longer survival in patients with colorectal cancer: Study
Coffee drinkers may have an edge against colon cancer, new research suggests.
Researchers now better understand ovarian cancer tumors and treatment outcomes
After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the composition of ovarian cancer tumors changes during chemotherapy and contributes to therapeutic response.
Major trial uses blood test to match women with breast cancer to precision treatments
A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal.
UK prostate cancer referrals have dropped by half since lockdown, figures show
Prostate cancer referrals have halved since the beginning of lockdown as thousands of men put off seeing their GP.
Significantly shorter drug therapy is just as effective for some breast cancer patients as long-term options
Scientists in India have found that women identified in the early stages of breast cancer can be treated with a short-term therapy that's as effective as its longer-term alternative. The study's clinical trials also show lower rates of cardiac toxic effects.
Cancer and its treatment may accelerate the ageing process in young patients
A new study examines the effects of cancer and its treatment on the ageing process. Investigators found that expression of a gene associated with ageing is higher in young patients with cancer after treatment with chemotherapy and in young cancer survivors who are frail. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society (ACS).
Why young and female patients don't respond as well to cancer immunotherapy
Cancer immunotherapy — empowering a patient's own immune system to clear away tumors on its own — holds great promise for some patients. But for other patients, immunotherapy just doesn't work.
Colorectal cancer: Diagnosis and treatment
With more than 1.8 million new cases reported in 2018 — a 9.5 percent increase compared to 1990 — colorectal cancer is the world’s third most prevalent form of cancer: The second most common cancer type in women and the third most common for men.
Study finds cancer mapping may solve puzzle of regional disease links
Researchers from Queensland University of Technology (QUT) in Queensland, Australia, have used nationwide cancer mapping statistics of their country to develop a new mathematical model so health professionals can further question patterns relating to the disease.
US sanctions seriously affecting treatment of Iranian patients: Iranian lawyer
A prominent Iranian lawyer criticized the illegal sanctions imposed by the United States on Iran, which have seriously affected the treatment of Iranian patients and stressed the need to punish those who have imposed the sanctions.
Not all cancer patients should be regarded as vulnerable to COVID-19: Expert oncology group
Oncologists managing patients during the COVID-19 pandemic have been urged not to delay cancer treatment that could impact on patients’ survival, as not all cancer patients should be regarded as ‘COVID-19 vulnerable’.
Scientists test 'bispecific' antibody that helps T cells zero in on treatment-resistant cancers
Although immunotherapy has achieved increasing prominence in the panoply of innovative cancer treatments, it remains an imperfect tool — too many tumors simply do not respond.

Page Generated in 3/1140 sec